Nephrotect (Acetylcysteine, Glycine, L-Lysine Acetate, L-Tryptophan, Glycyl-Tyrosine, L-Arginine, L-Histidine, L)

Acetylcysteine serves as a precursor to glutathione, a key intracellular antioxidant. By replenishing glutathione stores, it helps reduce oxidative damage in kidney cells, while the accompanying amino acids provide substrates for protein synthesis and metabolic pathways that further support renal health.

The dosage of Nephroprotect is determined by the prescribing clinician based on the patient’s clinical condition, weight, renal function and the intended therapeutic goal. Healthcare professionals set the appropriate infusion rate and total volume.

Safety data for Nephroprotect in pregnancy or lactation are limited. The product should only be used if the potential benefit justifies any potential risk to the fetus or infant, and this decision must be made by a qualified healthcare provider.

To order Nephroprotect, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and required import documentation.

Nephroprotect combines acetylcysteine with a broad spectrum of amino acids, offering both antioxidant and metabolic support. Compared with single‑ingredient agents such as plain acetylcysteine, the multi‑component blend may provide additional substrates for renal cell repair, though comparative clinical data are limited.

Nephroprotect should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight and extreme temperature fluctuations to maintain stability.

Nephroprotect is given by intravenous infusion. The solution is added to a compatible IV bag or syringe and administered over a period defined by the prescriber, typically under continuous monitoring of vital signs.

Serious risks include anaphylactoid reactions, severe hypotension, angio‑edema, and acute renal dysfunction. Immediate medical attention is required if any signs of severe allergic response, sudden blood pressure drop, or worsening kidney function occur.

Nephroprotect should be avoided in patients with known hypersensitivity to acetylcysteine or any of its amino‑acid components, and in individuals who have experienced severe anaphylactoid reactions to similar intravenous formulations. Clinicians should also exercise caution in patients with unstable cardiovascular status.